What is BPC-157?
BPC-157 (Body Protective Compound 157) is a 15-amino acid synthetic peptide derived from a protein found in human gastric juice. It has been one of the most extensively studied peptides in pre-clinical research over the past two decades, with a broad range of investigated biological activities centered on tissue repair, angiogenesis, and anti-inflammatory mechanisms.
What BPC-157 Is
BPC-157 is a pentadecapeptide — a chain of 15 amino acids — that was isolated from a protein found in human gastric juice. Its full designation is Body Protective Compound 157, reflecting its origin in gastric protective research. Unlike many research peptides that are analogues of hormones or growth factors, BPC-157 has no known endogenous human counterpart; it is a synthetic peptide derived from a partial sequence of a gastric protein.
The peptide is water-stable and orally active in animal models, which distinguishes it from many other peptides that are rapidly degraded in the gastrointestinal tract. This stability has made it a subject of considerable research interest for systemic administration routes.
Mechanism of Action
Research into BPC-157's mechanism of action has revealed several pathways that may account for its broad range of observed effects in animal models:
Angiogenesis: BPC-157 has been shown to upregulate VEGF (vascular endothelial growth factor) expression and promote the formation of new blood vessels. This is believed to be a primary mechanism by which it accelerates tissue healing in tendon, ligament, and muscle research models — new blood supply to injured tissue is a critical rate-limiting step in repair.
Nitric oxide modulation: Research has demonstrated that BPC-157 modulates nitric oxide (NO) synthesis. It appears to protect endothelial function and may normalize NO signaling disrupted by injury or inflammation.
Growth factor receptor upregulation: Studies have shown BPC-157 upregulates receptors for growth factors including EGF (epidermal growth factor) and increases expression of early response genes involved in tissue repair.
Anti-inflammatory effects: In animal models, BPC-157 has demonstrated reduction of inflammatory markers and protection against inflammation-induced tissue damage across multiple organ systems.
Research Applications
BPC-157 has been investigated across a remarkably broad range of tissue types and injury models in pre-clinical research:
| Research Area | Model Type | Observed Effect |
|---|---|---|
| Tendon repair | Rodent transection models | Accelerated healing, increased tensile strength |
| Muscle repair | Crush injury models | Reduced recovery time, improved function |
| Ligament healing | Transection models | Improved structural integrity |
| GI mucosal protection | NSAID/ethanol models | Reduced ulceration, accelerated healing |
| Bone healing | Defect models | Increased bone density at repair site |
| Corneal repair | Alkali burn models | Reduced scarring, improved healing |
The breadth of these research applications is unusual among peptides and reflects BPC-157's multi-pathway mechanism of action rather than receptor-specific activity.
BPC-157 + TB500 Combination Research
A common area of research interest is the combination of BPC-157 with TB-500 (synthetic Thymosin Beta-4). The rationale is mechanistic complementarity: BPC-157 is believed to have stronger localized effects at injury sites through angiogenesis and growth factor upregulation, while TB-500 has broader systemic distribution and operates primarily through actin-binding mechanisms that promote cell migration and differentiation.
J.Pharma supplies a pre-combined BPC-157 + TB500 vial (20mg blend) for researchers investigating dual-mechanism tissue repair models.
Reconstitution for Research
BPC-157 is supplied as a lyophilized (freeze-dried) powder and must be reconstituted with Bacteriostatic Water before use in research protocols.
Standard protocol for 20mg BPC-157 + TB500 blend: Add 2mL Bacteriostatic Water to the vial for a 10mg/mL concentration. Inject BAC Water slowly down the vial wall — do not aim directly at the powder cake. The blend may take 60-90 seconds of gentle swirling to fully dissolve. Solution should be clear and colorless. Refrigerate at 2-8°C after reconstitution. Stable 28-42 days.
For full reconstitution parameters and dosing calculator, visit our Reconstitution Guide and Dosing Calculator.